The Future of Healthcare Symposium
Pepperdine Graziadio Business School will host its 5th annual Future of Healthcare Symposium on March 21, 2019 at The Ritz-Carlton in Marina del Rey. Speakers at this year’s symposium, Healthcare Leadership in the AI Revolution: Opportunity in the Smart Machine Age, will discuss industry changes that leaders will need to know in order to navigate the smart machine age and the introduction of artificial intelligence to the healthcare space.
The first 400 registrants will receive a complimentary copy of Dr. Topol’s new book, Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again, which he will be signing at the event.
The 5th Annual Future of Healthcare Symposium brings together influential thinkers and experienced practitioners to discuss the opportunities and challenges with using artificial intelligence and technological innovations to improve healthcare efficiencies, access to care and patient outcomes. Attendees can network with peers to share best practices and discuss collaboration opportunities. Register and view the full agenda here.
Keynote speakers include:
Jeff Stibel, PhD is the former CEO of Web.com (NASDAQ: WWWW), vice chairman of Dun & Bradstreet (NYSE: DNB), and a partner of Bryant Stibel. He is a USA Today columnist and a New York Times bestselling author of two books, Breakpoint and Wired for Thought. Stibel was the recipient of a brain and behavior fellowship while studying for a PhD at Brown University and received an honorary doctorate degree from the Pepperdine Graziadio Business School.
In his presentation, Brain Science Is Smart Science, Jeff Stibel introduces us to brain science, "real” intelligence, and how his company, BrainGate, is using AI to advance neuroscience and treat those with neurological disorders. Stibel also offers a practical application of brain science and how to keep your brain healthy in the modern digital age.
Eric Topol, MD is one of the leading innovators in medicine today, specializing in the use of artificial intelligence, “deep” data, and smart technology in the practice of individualized medicine. He is the Founder and Director of The Scripps Translational Science Institute and is also Executive Vice President of The Scripps Research Institute and Professor of Molecular Medicine. Britain’s National Health Service has called on Dr. Topol to lead a review into how the NHS can pioneer new treatments and technologies to transform healthcare. Dr. Topol will look at technologies such as artificial intelligence (including robotics), genomics and digital medicine and how to train tens of thousands of staff at the NHS.
In his presentation, Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again, Dr. Eric Topol explores the far-reaching changes that smart technology and smart machines are having (and will have) on the practice of medicine and the experience of providing and receiving healthcare.
Morning Panel: The Intersection of Smart Technology and the Business of Healthcare
Panelists will discuss how bringing to life new business models and proofs of concept, smart technology is generating progressive clinical trials and enhancing patient experiences and outcomes.
Kim Kamdar, PhD, a partner at Domain Associates, has been involved in cutting-edge therapeutic start-ups and has been a major part of identifying companies with promising molecular and companion diagnostics to support personalized medicine.
Belinda Tan, MD, PhD, co-founder and chief medical officer at Science 37, is a physician-scientist and educator. As an entrepreneur, she is driven by the audacious goal of building a universal medical-scientific ecosystem that will connect all people to scientists. Prior to starting Science 37, Dr. Tan joined a team of physicians to build the nationally scaled telemedicine company DirectDerm, whose services have improved health outcomes throughout central California.
Visar Berisha, PhD is the co-founder and chief science officer of Aural Analytics, an assistant professor at Arizona State University, and a research fellow in the department of neurology at Mayo Clinic. With a focus on speech and language production, his research focuses on using technology to better understand neurological disease progression.
Afternoon Panel: Applying Smart Tech: Leading the Way
This panel focuses on how input (data reliability, validity and potentials for bias) designates output from live case studies as well as how ethics and evidence-based decision-making are leading the way in healthcare.
Rajan Merchant, MD is a board certified allergist-immunologist based in Woodland, California. For his 18 years of experience, Dr. Merchant has been recognized by the Dignity Health Leadership Development Program, and has been named one of Sacramento Magazine's top allergy doctors for three consecutive years: 2016, 2017, and 2018. Most recently Dignity Health and Propeller Health was selected as the Grand Award for 2019 Intelligent Health Association Improving Patient Care and Safety Award with Dr. Merchant being designated the physician champion.
Samuel Seaman, PhD is a professor of decision sciences at the Graziadio Business School, where he teaches graduate courses in applied statistics and evidence-based decision analysis using mathematical models to solve dilemmas in economics, finance, healthcare, and marketing.
Lisa Watanabe, MD is the Chief Medical Officer at CureMetrix, which is leveraging artificial intelligence to develop the next generation of medical image analysis technology for mammography. Dr. Watanabe is an Associate Clinical Professor of Radiology at USC and in 2017 she received the Women in Neuroradiology Leadership Award from the American Society of Neuroradiology.
The Pepperdine Graziadio Business School is also celebrating its 50th anniversary this year and will also be discussing the impact of artificial intelligence and automation at its “Future of Humanity in the Smart Machine Age” event on April 2 at The Novo in Downtown Los Angeles.